PH24934A - Medicaments for the treatment of addition - Google Patents
Medicaments for the treatment of additionInfo
- Publication number
- PH24934A PH24934A PH36099A PH36099A PH24934A PH 24934 A PH24934 A PH 24934A PH 36099 A PH36099 A PH 36099A PH 36099 A PH36099 A PH 36099A PH 24934 A PH24934 A PH 24934A
- Authority
- PH
- Philippines
- Prior art keywords
- methyl
- medicaments
- treatment
- addition
- abuse
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868627909A GB8627909D0 (en) | 1986-11-21 | 1986-11-21 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PH24934A true PH24934A (en) | 1990-12-26 |
Family
ID=10607734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH36099A PH24934A (en) | 1986-11-21 | 1987-11-20 | Medicaments for the treatment of addition |
Country Status (16)
Country | Link |
---|---|
US (1) | US4847281A (ja) |
EP (1) | EP0278161B1 (ja) |
JP (1) | JPH0830008B2 (ja) |
KR (1) | KR950010148B1 (ja) |
AT (1) | ATE74271T1 (ja) |
AU (1) | AU608788B2 (ja) |
CY (1) | CY1694A (ja) |
DE (1) | DE3778008D1 (ja) |
DK (1) | DK612787A (ja) |
ES (1) | ES2033879T3 (ja) |
GB (1) | GB8627909D0 (ja) |
GR (1) | GR3004252T3 (ja) |
HK (1) | HK36793A (ja) |
IE (1) | IE61033B1 (ja) |
PH (1) | PH24934A (ja) |
ZA (1) | ZA878702B (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
JP2765845B2 (ja) * | 1986-11-21 | 1998-06-18 | グラクソ、グループ、リミテッド | 中止症候群の予防の治療薬 |
US5198459A (en) * | 1987-07-11 | 1993-03-30 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
US5272168A (en) * | 1987-07-11 | 1993-12-21 | Sandoz Ltd. | Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents |
DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
GB8820650D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
US5397782A (en) * | 1990-06-13 | 1995-03-14 | Janssen Pharmaceutica N.V. | Method of treating addiction to alcohol |
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
US5726644A (en) * | 1995-06-30 | 1998-03-10 | Philips Electronics North America Corporation | Lighting control system with packet hopping communication |
US5824684A (en) * | 1997-02-21 | 1998-10-20 | Synapse Pharmaceuticals International, Inc. | Method for treating drug and alcohol addiction |
US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
WO2010065930A1 (en) * | 2008-12-04 | 2010-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating or preventing narcotic withdrawal symptoms |
US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
US20110288115A1 (en) * | 2010-05-24 | 2011-11-24 | Avmedis Llc | Treatment of vagally-mediated spectrum disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499096A (en) * | 1983-11-18 | 1985-02-12 | Lotsof Howard S | Rapid method for interrupting the narcotic addiction syndrome |
FI84349C (fi) * | 1984-01-25 | 1991-11-25 | Glaxo Group Ltd | Foerfarande foer framstaellning av en farmakologiskt vaerdefull foerening. |
DE3688296T2 (de) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | Arzneimittel zur behandlung von erbrechen. |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
PH23937A (en) * | 1986-12-16 | 1990-01-23 | Robins Co Inc A H | Anxiolytic-n-(1-azabicyclo(2.2.2.)oct-3-yl)benzamides and thiobenzamides |
DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
-
1986
- 1986-11-21 GB GB868627909A patent/GB8627909D0/en active Pending
-
1987
- 1987-11-20 PH PH36099A patent/PH24934A/en unknown
- 1987-11-20 ZA ZA878702A patent/ZA878702B/xx unknown
- 1987-11-20 KR KR1019870013069A patent/KR950010148B1/ko not_active IP Right Cessation
- 1987-11-20 DE DE8787310289T patent/DE3778008D1/de not_active Expired - Lifetime
- 1987-11-20 ES ES87310289T patent/ES2033879T3/es not_active Expired - Lifetime
- 1987-11-20 EP EP87310289A patent/EP0278161B1/en not_active Expired - Lifetime
- 1987-11-20 IE IE315687A patent/IE61033B1/en not_active IP Right Cessation
- 1987-11-20 AT AT87310289T patent/ATE74271T1/de not_active IP Right Cessation
- 1987-11-20 DK DK612787A patent/DK612787A/da not_active Application Discontinuation
- 1987-11-20 JP JP62293894A patent/JPH0830008B2/ja not_active Expired - Lifetime
- 1987-11-20 AU AU81443/87A patent/AU608788B2/en not_active Ceased
- 1987-11-20 US US07/123,369 patent/US4847281A/en not_active Expired - Lifetime
-
1992
- 1992-04-02 GR GR920400436T patent/GR3004252T3/el unknown
-
1993
- 1993-04-15 HK HK367/93A patent/HK36793A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169494A patent/CY1694A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE74271T1 (de) | 1992-04-15 |
GR3004252T3 (ja) | 1993-03-31 |
JPH0830008B2 (ja) | 1996-03-27 |
HK36793A (en) | 1993-04-23 |
KR950010148B1 (ko) | 1995-09-11 |
JPS63185927A (ja) | 1988-08-01 |
EP0278161A1 (en) | 1988-08-17 |
US4847281A (en) | 1989-07-11 |
EP0278161B1 (en) | 1992-04-01 |
DK612787A (da) | 1988-05-22 |
DE3778008D1 (de) | 1992-05-07 |
GB8627909D0 (en) | 1986-12-31 |
AU8144387A (en) | 1988-05-26 |
DK612787D0 (da) | 1987-11-20 |
CY1694A (en) | 1994-01-14 |
AU608788B2 (en) | 1991-04-18 |
IE61033B1 (en) | 1994-09-07 |
IE873156L (en) | 1988-05-21 |
ES2033879T3 (es) | 1995-04-01 |
KR880005930A (ko) | 1988-07-21 |
ZA878702B (en) | 1988-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH24934A (en) | Medicaments for the treatment of addition | |
IL116203A (en) | Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron | |
EP0392959A3 (en) | Use of sertindole for the treatment of schizophrenia | |
GEP20022752B (en) | Valaciclovir Tablets Containing Colloidal Silicon Dioxide | |
HU9502193D0 (en) | Combination treatment for inhibiting bone loss | |
HU9603042D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration | |
ZA879458B (en) | Medicaments | |
IL108234A0 (en) | Pharmaceutical composition containing galanthamine | |
GB2223168B (en) | Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes | |
HU901085D0 (en) | Process for producing substituted benzimidazole and pharmaceutical preparatives containing it | |
RO116771B1 (ro) | Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine | |
AU638083B2 (en) | Swallowable dosage units comprising colloidal bismuth subcitrate | |
ZA925146B (en) | Pharmaceutical agent for treatment of withdrawal symptoms. | |
CA2118512A1 (en) | Agents for treating substance abuse disorders | |
IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
IE873231L (en) | Medicaments | |
EP0495226A3 (en) | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma | |
IL89654A (en) | Pharmaceutical combination compositions for treating hypertension | |
MX9703032A (es) | Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxi lato de 2-[n-(1,2-benzisotiazolil-3(2h) ona-1,1-dioxido]etilo. | |
TW357092B (en) | Transport of solid medicament components |